GlassScriptPhysician profile
Alicia Su
NPI 1811223001
$4,709.72
in general payments reported to CMS, 2019-2025
21 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $1,625 · 2023: $1,881 · 2024: $419 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Travel and Lodging: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.16 |
| Travel and Lodging | $994.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,987.95 | 2023-2025 | Watchman Access System, Farapulse, Rhythmia Mapping System |
| Zoll Respicardia, INC. | $1,347.96 | 2022 | |
| Abbott Laboratories | $476.88 | 2022-2025 | Gallant, Accent, Assurity |
| Novartis Pharmaceuticals Corporation | $179.84 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $109.02 | 2021-2023 | |
| Pfizer INC. | $89.10 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $80.09 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $63.02 | 2022-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.90 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $47.01 | 2021-2022 | |
| Cardiva Medical, INC. | $39.84 | 2022 | |
| Philips North America LLC | $34.59 | 2024 | (Ck7) Extended Holter |
| Merck Sharp & Dohme LLC | $32.83 | 2021-2022 | |
| Medtronic, INC. | $30.79 | 2024-2025 | Mycarelink |
| Actelion Pharmaceuticals US, INC. | $27.13 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $23.82 | 2024 | Sotalol Hydrochloride |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.55 | 2024 | Lifevest |
| Novo Nordisk INC | $18.02 | 2025 | Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $18.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.35 | 2021 | |
| Elutia, INC. | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.